RegentAtlantic Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $229K | Hold |
|
|||||
|
2022
Q2 | $210K | Hold |
|
|||||
|
2022
Q1 | $250K | Hold |
|
|||||
|
2021
Q4 | $226K | Hold |
|
|||||
|
2021
Q3 | $350K | Sell |
|
|||||
|
2021
Q2 | $669K | Hold |
|
|||||
|
2021
Q1 | $399K | Sell |
|
|||||
|
2020
Q4 | $549K | Sell |
|
|||||
|
2020
Q3 | $469K | Buy |
|
|||||
|
2020
Q2 | $245K | Buy |
|
|||||
|
2020
Q1 | $277K | Sell |
|
|||||
|
2019
Q4 | $421K | Hold |
|
|||||
|
2019
Q3 | $374K | Hold |
|
|||||
|
2019
Q2 | $316K | Sell |
|
|||||
|
2019
Q1 | $246K | Sell |
|
|||||
|
2018
Q4 | $240K | Buy |
|
|||||
|
2018
Q3 | $370K | Hold |
|
|||||
|
2018
Q2 | $221K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $390K | Hold |
|
|||||
|
2017
Q3 | $383K | Hold |
|
|||||
|
2017
Q2 | $334K | Hold |
|
|||||
|
2017
Q1 | $156K | Hold |
|
|||||
|
2016
Q4 | $151K | Hold |
|
|||||
|
2016
Q3 | $165K | Hold |
|
|||||
|
2016
Q2 | $225K | Buy |
|